BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16550700)

  • 41. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone].
    Nemec K
    Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163
    [No Abstract]   [Full Text] [Related]  

  • 43. Haloperidol in the treatment of nausea and vomiting due to cytotoxic drug administration.
    Plotkin DA; Plotkin D; Okun R
    Curr Ther Res Clin Exp; 1973 Sep; 15(9):599-602. PubMed ID: 4201543
    [No Abstract]   [Full Text] [Related]  

  • 44. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Centrally acting antiemetics mitigate nausea and vomiting in patients with Alzheimer's disease who receive rivastigmine.
    Jhee SS; Shiovitz T; Hartman RD; Messina J; Anand R; Sramek J; Cutler NR
    Clin Neuropharmacol; 2002; 25(2):122-3. PubMed ID: 11981242
    [No Abstract]   [Full Text] [Related]  

  • 47. Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain.
    Sutton IR; Daeninck P
    J Support Oncol; 2006; 4(10):531-5. PubMed ID: 17136871
    [No Abstract]   [Full Text] [Related]  

  • 48. Should anaesthetists be giving dexamethasone to patients with malignancy?
    Hoyle J; Williams A
    Br J Hosp Med (Lond); 2011 Aug; 72(8):478. PubMed ID: 21841601
    [No Abstract]   [Full Text] [Related]  

  • 49. Association of chemotherapy related nausea and vomiting with pretreatment anxiety.
    Rhodes VA; Watson PM; Johnson MH
    Oncol Nurs Forum; 1986; 13(1):41-7. PubMed ID: 3632859
    [No Abstract]   [Full Text] [Related]  

  • 50. [No tumor therapy without adequate supportive plan].
    Aumiller J
    MMW Fortschr Med; 2006 Feb; 148(5):4-6, 8. PubMed ID: 16518927
    [No Abstract]   [Full Text] [Related]  

  • 51. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antiemetics in cytostatic-induced vomiting].
    Jungmayr P
    Med Monatsschr Pharm; 2010 Feb; 33(2):49-54; quiz 55-6. PubMed ID: 20184263
    [No Abstract]   [Full Text] [Related]  

  • 54. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract]   [Full Text] [Related]  

  • 55. Transdermal patch tailors antinausea treatment.
    Morrow T
    Manag Care; 2008 Dec; 17(12):47-8. PubMed ID: 19127767
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Hartvig P
    J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570
    [No Abstract]   [Full Text] [Related]  

  • 57. Olanzapine for Chemotherapy-induced Nausea and Vomiting Pediatric Population: Take Home Message?
    Singh A; Gupta D
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):178-179. PubMed ID: 38447066
    [No Abstract]   [Full Text] [Related]  

  • 58. Patients' response to revised practices for treating chemotherapy-induced nausea and vomiting.
    Steinberg M
    Am J Health Syst Pharm; 2005 Mar; 62(5):463. PubMed ID: 15745904
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
    Chan A; Shih V; Chew L
    J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.